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Abstract

Introduction

Computerised image-analysis
was used to
quantitate
small intestinal
mucosae from celiac
sprue and dermatitis
herpetiformis
patients,
Gambian
children
with
tropical-sprue-like
malabsorption,
first-degree
celiac
sprue relatives,
and treated celiac sprue patients
during
challenge with
a peptic-tryptic
digest of
gluten. A wide range of mucosal appearances was
observed. Typically,
'flat'
lesions
(Type 2)
revealed
a reduced
number of
epithelial
lymphocytes that were
large and mitotically
active.
At the other extreme, mucosal architecture was relatively well preserved (Type 1) but
surface epithelium contained an expanded population of small, non-mitotic lymphocyte s, with or
without crypt hyperplasia.
Simil ar changes were
observed in one-third of celiac
re lative s and
following small dose gluten challenge.
Larger
dose challenges revealed a transition from Type
1 to Type 2 lesions over a 5-day period. Studies
in a few patients
over 2-4 years showed a
similar
type of progression. A major feature
of
this sequence was early appearance of crypt
hypertrophy while villi persisted,
indicating
a
ro le for factors other than increased l oss of
enterocytes
from surface
epithelium.
These
changes parallel
the
T lymphocyte-mediated
events
in
graft-versus-host
reactions
in
animals . It is thus concluded that the spectrum
of immunopathologic changes observed in gluten
sens itivity
is
fundamentally a cell-mediated
effect, the degree of change being contro lled by
host genetic factors.
In becoming flat,
it
appears obligatory
for the mucosa to evolve
through the earlier Type 1 lesion in which crypt
hypertrophy is a prominent response .

The classic studies of the Dutch workers
Dicke , Weijer s
and van der Kamer [24,52]
established
the central role of gluten protein
in the pathogenesis
of
celiac
sprue (CS).
Although CS was considered to be a disease of
children,
it became evident, by 1960 [99,105]
that some adults previously lumped together
in
an amorphous diagnostic group termed "idiopathic
steatorrhoea",
had an identi ca l condition by
virtue of a simi lar lesion of upper jejunal
mucosa ( "subtotal
villous atrophy").
Thus, CS
came to be regarded as a life-long
disorder
[84], while the combined use of jejunal
biopsy
and a gluten-free diet subsequently showed that
after
a few years
of treatment,
complete
morphological restoration
of jejunal
mucosal
architecture
could be expected [2,122].
The term
"subtotal
villous
atrophy"
embraced a lesion comprising loss of surface
villi
associated
with
shortened,
cuboidal
epithelial
cell profiles, marked hypertrophy of
the crypts,
and a chronic inflammato ry cell
infiltrate
of the 1amina propri a. Another 1es s
severe le sion, termed "partial villous
atrophy"
was originally
[26,118]
considered to be a
distinct
entity
intermediate
in appearance
between normal and the more severe
"fl at"
lesion.
Although this terminology has unfortunately become engrained in the literature,
later
studies by SEM[63,74,75] and kinetic
analyses
of epithelial
cell turnover [ 120,121] showed
conclusively
that
there
is
a progressive
continuum of mucosal change between the two
extremes .
The abnormal epithelial
structure
in the
severe lesion seemed compatible with a major
theory of pathogenesis envisaged by Frazer [37].
This proposal saw epithelial
eel 1s, congenitally
lacking a "peptidase"
and hence unable to
complete the
digestion
of
gluten protein,
damaged by the direct action of an incomplete
breakdown product of gluten.
This idea is no
longer consistent
with
recent
concepts of
digestion,
transport and absorption of proteins
by mammalian intestine
[17,56,83,94,111]:
not
surprisingly,
there has been little
success in
identifying
the
missing
peptidase [13,95].
Furthermore,
the gradual realisation
that CS
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patients
(i) have antibodies
to gluten and
lymphocytes reactive to gluten protein in vitro
(ii)
exhibit
splenic
atrophy and mesenteric
lymph node cavitation (iii) may develop T cell
lymphomas and (iv) are genetically-predisposed
by virtue of certain
HLA Class II D-locus
allospecificities,
indicated widespread involvement of the immune system in this condition
[3,21,22,42,45,46,47,48,49,53,55,57,82,92,93,103,
112,115].
More specifically,
the demonstration
of
a
rise
in
the
relative
density of
interepithel ial eel l space lymphocytes (EL) in
untreated
CS patients [33] was one of the first
major studies indicating that CS is primarily
an
immune-mediated condition.
Interest
in the
importance of EL was
stimulated
by their
close proximity to the
intestinal
lumen, suggesting that they might
play a major role in "immune surveillance"
at
this
strategic
host-environment
frontier
[5,25,29,31,72].
With others
[18,64,100] we
initially
discovered the
presence of blasttransformed EL within murine small intestine
and
that these lymphocytes have a high mitotic
rate
[46,47,65,67,69,97].
At that time it seemed
reasonable
to suppose that EL were reacting
to
antigen traversing
the intestinal
epithelium.
It thus followed that if CS were due to local
immunisation to gluten peptide s , then similar
changes in the EL population might be expected
in
the
target
of immunologically-sustained
damage - the upper jejunal mucosa [68] .
The purpose of this review is to summarise
our principal findings regarding EL populations
in
CS in
relation
to
the
background
morphological appearances referred to above.
In
studyi ng
the
entire
range
of
"gluten
sensitivity",
which includes patients with overt
CS [66] and dermatitis herpetiformis
(DH) [8],
first-degree
relatives
of
known CS patient s
[80], together with the effects of graded oral
challenges
of gluten peptides on treated
CS
patients
[58],
a much wider
spectrum of
immunopathologic changes
has emerged.
While
such studies are
still
being pursued, the
results
closely
parallel
events accompanying
various models of graft-ver sus-ho st reaction
(GVHR) and allograft rejection
in experimental
animals [32] . It is on this latter
background
that the varied features of the celiac
lesion,
as well
as
those
associated
with other
presumptive 'immune' disorders
of the small
intestine,
such
as
tropical
sprue
and
giardiasis,
may be more effectively
evaluated.
Together,
they
suggest
that
in all these
conditions,
the various degrees of intestinal
involvement are
(i)
reflections
of T cell
lymphocyte-medi ated attack and (ii) dependent on
a specific (genetica ll y-mediated) host response
for their expression .

18-65)
comprising
patients
referred
with
gastrointestinal
symptoms but in whom jejunal
morphology was judged to be normal and CS not
considered to be the diagnosis;
a group of
misce llan eous
patients
(age
range :
28- 72)
accompanied by a 'flat' mucosa (FDC) that was
not considered due to gluten sensitivity
[76]:
among this group were patients
with jejunal
Crohn' s
disease,
a -chain
disease,
small
intestinal
lymphom
a and common variable
immunodeficiency.
Celiac Sprue. Mucosae were obtained from
among 25 patient s
(age
range: 21-68) with
diarrhea,
malabsorption
or
anemia as
a
diagnostic procedure, and who were s hown to have
a flat mucosa in which the percentage mitotic
index of EL > 0.2% [69]: note that this index in
the non-CS flat disease-control
group was <0.1%
[76].
Mucosae were also obtained from these
patients
at varying times during treatment with
a gluten-free
diet.
At that stage,
patients
were in good health, without malabsorption or in
need of nutritional
supplements,
and in whom
there was histological
evidence of improved
mucosal architecture.
Dermatitis Herpetiformi s. These comprised a
group of 30 subjects with pruritic,
eruptive
skin vesicles
appearing
on face,
shoulders,
elbows and knees, and in whom immunofluorescence
of uninvolved
sk in
revealed linear/granular
deposits of IgA [54]. They were referred
by
physicians
at
the
Manchester
Hospital for
Diseases of the Skin. Treatment was with ora l
dapsone and gluten-free diet:
gluten-sensitivity
was demonstrated either by marked histologica l
changes in jejunal mucosa and/or by subse quent
challenge with gluten, or derivatives thereof.
First-Degree CS Relatives. A sample of 52
first-degree
CS relatives was s tudied in terms
of
HLA status,
mucosal
morphology,
EL
populations,
and permeability
to the probe
5l(r-EDTA (ethylene
diamino
tetra-acetate)
[13,14]. Relatives (symptomatic or asymptomatic)
with
pre-e xisting
flat
jejunal
mucosae
(prevalence
15.5% of
200 relatives)
were
excluded from this particular study [8] .
IRJTiunogens
Gluten. Peroral challenges in healthy volunteers and treated CS patients
were performed
with a peptic-tryptic
digest of crude commercial
gliadin
(Sigma)
as
originally
described by
Frazer and coll eagues [ 38] and modified by Jos
et al [51] . Dose ranges were 0.1, 0 .5, l, 1.5,
3.0, 6gm.
Contro l . 500mg of B-lactoglobulin
(BDH) was
used as a control challenge immunogen.
Challenge Protocol
Pat ients and controls were admitted to a
metabolic ward for 5 days [58]. On the morning
of day 1, a cont rol jejunal biopsy was performed
and at 10pm the se le cted dose of immunogen was
given by mouth. The first post-challenge
biopsy
was performed at 10am on the morning of day 2,
i.e . , 12h after
the challenge immunogen was
ingested.
Subsequent bio psies were obtai ned on

Materials and Methods
Subjects Studied
Controls. These were either
healthy young
volunteer s (HV)
(age
range: 20-26); family
member contro l s of known CS subjects (FMC
) (age
range: 24-58); disease-controls
(DC) (age range:
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the morning of the 3 remaining days, at
and 84h after chal l enge.

36,

g

Control s

60
Surface
epith elium

Hi stolog ic Techni que
Mucosal tissue was obtai ned under fluoroscopic control from the first loop of jejunum by
Watson, or
Quinton hydaulic mul tiple-biopsy,
instruments.
Specimens were quick l y retrieved
within 0.5 min, gently spread on cards and fixed
in either Dalton's chrome-osmium fixative
[20]
or
(more recently)
with
2.5%
ultrapure
glutaraldehyde
buffered
with
O.l M
sodium
cacodylate
to pH 7.2: these specimens were
post-fixed in 1% osmium tetroxide for 1 h.
All specimens were routinely processed into
Araldite
plastic,
sectioned at lµm on Sorva l l
MT2-B or Reichert
OMU-3 ul tramicrotomes and
stained with toluidine bl ue.
Six consecutive
lµm sections
were mounted per slide and lOµm
st eps were discarded between successive
slides.
Only one section per slide was analyzed, the one
chosen being least subject to preparative
or
technical
artefact.
The remaining sections
served for verification
of cytologic
detail
if
required,
while
the
intervening
lOµm step
ensured that no cell was counted twice.
With
some analyses,
several
parts of the chosen
section were used, but no observations
were
duplicated
on the
same part of individual
sections .
Care was taken to ensure that the
bulk of the speci men was sectioned vertica l to
the
surface
mucosal
pla ne .
Appropriate
micrographs were recorded on Ilford FP3 high
grain film through either Zeiss "Photomicroscope
III " or Olympus BH2-S research microscopes.

Untr eated CD

13

T reated CD

~

Crypt
e pithel ium

Lami na propria

[3
Muscula ris Mucosae

Fig ure 1.
This
diagram
represents
mucosal
components for lamina propria, surface and crypt
epithelium in control subjects and patients
with
untreated,
and treated celiac
sprue, expressed
as equivalent cube volumes T~e means for each
group of measurements (xlO6µm) accompany each
cube, the faces of which are drawn to scale to
permit quantitative
comparison. All measurements
are controlled by reference to the constant test
area of muscul aris mucosae .

[41] by adding the smallest profiles (left
hand
25% of
distribution)
determined by scaling
existing
values up to a line joining the zero
or igin with the half-value of the mode.
he
mean of this di s tribution was multipl ied by ITT
to
correct
for
imperfe ct
(non-sagit tal)
sect ioning [117].
In this way, the true mean
nuclear diameter (DN) of EL (surface or crypt
epithelium) per specimen was obtained.
From each
corrected
distributi on, the
percentage of
nuclei
with
DN > 6µm (%
'immunoblastoid' lymphocytes) was obtained.
Calculation of Absolute EL population (Nv)
~SE
or VciJ · In attempting to determine the
absolute number of
a population of cells
contained within a defined tissue component, of
volume V, the true ctiameter of those cells must
be known [77], since each sectioned "profile"
of
a cell observed in a section of known thickness
(t µm) represents only a fragment of the whole
cell.
It has
been shown [117] that all
particles (diameter, D) whose profiles appear in
any finite
section of
t µm thickness
are
contained
in
a superslice
whose overa l l
t hickness (or ' effective sect i on thickness ' EST)
is given by the relationship:
EST
(t + D)µm
(1)
Since DN for
sur f ace or crypt EL was
calculated,
the total number of EL (N) occupying
VsE or VcR per specimen was obtained by counting
EL profi l es relative to 100 x lOOµm muscularis
mucosae per
specimen:
thus
Nv
[100 x
( l □□ ;EST)] units
of
tissue
vol ume.
Nuclear
profiles
were used in calcu l ating EST because
they are more
nearly circular
in sectioned

4

Morphometric Analysis of Mucosal Speci mens
Sections were examined through
an oilimmersion objective (xlOO) and analyzed with a
MOP-Videoplan (Kontron-Reichert)
image-analysis
sys tem. All measurements as detailed below, were
related,
dir~ct y or indirectly,
to a constant
test area (10 µm) of muscularis mucosae [71,91].
Mucosal Compartment Volumes (V5 E~CR-l~LP1·
For
the
determination
of
surface
epithe l ial volume (VsE), crypt epithelial
vol ume
(VcR) and lamina
propria
volume (VLP) per
specimen [91,79,23], the appropriate
sectioned
profiles in lµm epon sections were outlined with
the scr ibing cursor, and individually
cumulated
relative to a total length of 100 x lOOµm (10mm)
muscularis mucosae, thus approximating the test
area. Coefficients of variation
for successive
measurements per 100mmmuscularis per specimen
were <10%: these calculations are automatica l ly
inc l uded in the print-out by the manufacturer's
soft-ware programme.
Grouped values for VsE, VcR and VLP were
expressed
in terms of their
equivalent
cube
vol umes [71],
and depicted
graphical l y by
drawing their areal faces to scale (Fig. 1).
Mean Epithelial Diameters (DNl. The nucl ear
profiles
of 100 EL were traced with the cursor
per specimen: in previous work it was shown that
this popul ation size was sufficient
to achieve a
constant
mean ± SD.
The initia l
crude
distribution
for
nucl ear
diameters
was
subsequently modified to inc l ude "lost profiles"

2
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profile

and hence more accurately measured .
Percentage Mitotic Index (%MI) of EL. The
percentage mitotic index was calculated from the
number of metaphases observed in a total
sample
of 3000 EL in
surface epithelium only per
specimen [66], thus
avoiding confusion with
mitotic
precursors
in
the generative
crypt
epithelium. Furthermore, it has been shown [113]
that once
ascended
onto
the villi
mature
enterocytes,
goblet cells and argentaffin
cells
cease mitotic
activity.
In
flat mucosae,
proliferative
epithelial
cells
may
occur
throughout the
length
of the hypertrophied
crypts.
With such specimens, scoring of mitotic
figures
was strictly
confined_ to surface
epithelium,
crypt mouths being avoided.
.
.
In order to determine rates of EL mitosis
in vivo [66], four intramuscular
injections _ of
1.2mg colchicine at hourly intervals were given
to selected controls,
and CS patients,
both
before and during treatment with a gluten-free
diet. Jejunal biop s ies were performed before and
at variable time-points during the 4h oeriod of
mitotic
blockade .
The total
dose (4.8 mg)
administered was considered suitable
for this
purpose and was controlled by being shown to be
effective
in arresting
crypt epithelial
cell
mitotic activity during the study period [66].

Mitotic
Index

0 .5

0 .4

0.3
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0 .1
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oooooo e
00000000000
00000000000
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lmmunodeficiency

Neoplasias

D.H.

Coeliac
Disease

Figure 3. Percentage mitotic indices for EL in
various categories
of human small inte sti nal
biopsies
are illustrated.
In the majority of
control biopsies mitotic EL are rarely seen,
while in
gluten-sensitised
patient s (coeliac
disease,
dermatiti s herpetiformi s OH
and
eel iac-associated
lymphomas) with Type 2 lesi ons
( ■ ) the inde x usually exceeds 0.2%. OH patient s
with Type 1 le sions ( □ ), immunodeficiency (• ),
~on-gluten-induced lymphoma (.a.) or carcinomas
(X) , differ insignifica ntly from controls:
solid
symbols denote 'fl at'
biopsies.
EL in the
patient
with combined CS and immunodeficiency
( II) ) behaved l i ke other CS lymphocytes. Given a
flat
biopsy, an elevated index> 0.2% among EL
is a useful presumptive marker for CS disease.

Results and Discussion
Untreated CS Disease
In untreated CS (n = 14), mean corrected
nuclear diameter (ON) of surface EL was 5.6
±
0.2, compared witn 5.0 ± 0.1, 5.0 ± 0.2 and
4.9 ± 0.1 f or healthy volunteers (HV, n
10),
family members (FMC, n
10) and disease

contro l s (DC, n
10) with normal mucosal
struct ure, respectively
(p
< 0.001). With
remission on a gluten-free diet, ONfor treated
CS patients returned to the normal range.
These
data clearly show that the increased proportion
of immunoblastoid cells (Fig. 2) in untreated
CS
shi fts the distribution
to the right,
returning
to overlap the normal di strib ution for ON once a
singular
change in diet, removal of gluten,
had
occurred [66].
In determining the% mitotic index (MI) of
EL, values greatly exceeding 0.2% (Figs. 2,3)
were usually observed in untreated
CS patients
[66,69],
while a variety of control
subjects,
including some with flat-mucosae had lower MI <
0.1% [76]. In treated CS patients, MI for EL in
surface epithelium fell
below the arbitrary
cut-off
point (0.2%). Thus it was concluded
that activity of EL was reduced by the removal
of a single antigen only from the patients' diet.
The use of colchicine served to highlight
both the high basal mitotic activity of EL (Fig.
4) and the increased rate of arrival
of new
cells
into metaphase with time (Fig. 5).
The

Figure 2.
In the established
CS lesion,
EL
reveal an increase
in mitotic
activity
(LH
panel, arrow) and increase
in size:
some have
an
'immunoblastoid'
appearance
(RH panel,
arrow) . Bars= lOµm.
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Figure 5.
This illustrates
use of multiple
biopsies
during a 4h period of colchic ine
blockade in establishing rates of EL mitosis
(measured by % mitotic
index)
in two CS
patients,
before
(upper
curves),
and after
(lower curve s) , treatmentwith
dietary
gluten
restriction:
Note alterations
in
rates of
mitotic
activity.
Dotted l ines represent
95%
confidence limits.

dynamics of such changes were markedly reversed
by gluten-restriction
[66].
An investigation
int o the EL of crypt
epithelium
[79] was prompted by an observed
increase
in the flattened
mucosa of endemic
tropical
sprue patients [77,9 8]. Despite a 3-5
fo ld increase
in
VCR compared with various
control mucosae (1.7 x 10 µm vs 0.5-0.6
x
106µm3 ), a considerably elevated population of
EL ( ~ 180) was observed (Fig . 6), confined
predominantly to their upper regions (Fig. 7).
Even allowing for the scaling-up
of control
crypt volumes to those of untreated
CS crypts,
the latter
sti ll contain an excess of EL over
controls
that is
considered
to be gluteninduced. In parallel with their counterparts
in
surface epithelium,
ON for crypt EL was 5.7 ±
0.2, compared with controls
(4.9 ±0.1, p <
0.001),
reverting
to the control range with
dietary
gluten
restriction .
Note also the
marked increase
in large immunoblastoid cells
(DN > 6µm) (Fig. 8).
Paradoxically,
although the population of
crypt EL was considerab l y elevated
irrespective
of hypertrophy of crypt epithelium and fell
on
treatment
[ 79],
the
results
for
surface
epithelium were different,
the total
population
of EL in untreated CS mucosae being somewhat
lower (250} than the means (300-350} for each of
the various contro l groups [66]. Furthermore,
on
treat ment, the populat ion size for EL in surface
epithelium
increased to a mean of 370, while
that in crypts fell ( 180 to 60).
a wider

---I

Figure 4.
This
figure illustrates
1~i to tic
indices
(vertical axis ) for EL in control
and
CS patients, before and after treatment.
Basal
activity
in 10 controls
was zero, and no
additional
metaphases were observed after
a 4h
colchicine
blockade.
In contrast,
mitotic
indices in CS are raised, with a marked increase
with
colchicine:
after
treatment,
mitotic
indices fall almost to control values.

Dennatitis Herpetifonnis
In this condition,

I

I

CRYPT

LYMPHOCYTES(N)

200

t M+SE
100 •

HV

FMC

NOC

ucs

R_.CS

Figure 6 . Crypt lymphocytes (N) in untreated
CS
(UCS) are markedly
elevated over all other
control groups (HV - human volunteers:
FMC famil y
member contro l s:
NOC
normal
disease-controls:
FDC- flat-disease
contro l s)
and fall after treatment (R CS). Data reoresent
absolute population siz es refated to 104µmc test
area of muscularis mucosae.
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Nuclei >6µm

LJCytoplasm

6

>9JJm

4

2

0

HV

FMC

NOC

FDC

UCS

~S

Figure 8. Like sur face epithelium in CS, crypt
epithelium al so contains a high proportion ( ~ 8%)
of immunoblastoid EL over all other group s (see
Figure 6}.
Note that EL nuclear diameter s (>
6µm) provide a more accurate assessment of cell
size than cytoplasmic diameters( > 9µm) which
are subject to
greater
sectioning errors as
overall
size
increases.
In treated
(RCS)
cases,
size of lymphocyte s rapid l y returnsx to
control value s.

Figure 7.
This representative
lµm toluidine
blue-stained
micrograph illustrates
infiltrated
crypt epithelium in untreated CS. Note marked
heterogeneity
in
size
and appearance s of
lymphocytes (EL}.
Bar= lOµm. Note that EL
occupy upper zones of crypt epithelium.

( haemolysi s) leading to compensatory bone marrow
growth, may be incorrect.
In term s of EL, it can be seen that the
vi lli
to the left hand margin of the diagram
contain markedly increased population s of EL,
although the se are small and non-mit otic.
As
VsE fall s , the absolute number of EL drops, so
that for
flat
mucosae (right-hand
margin),
values lie around the low-normal range . In this
se tting,
however, EL are
large and highly
mit ot ic and thus identical in behaviour to tho se
in the classic CS le s ion, as detailed
above .
Conversely, note that as the cry pts hyper trophy,
their
content
of
EL progressively
rises:
furthermore,
with
severe
l es i ans, crypt EL
become larger, as in untreated CS crypt s [79].

morphologic changes were wrought on jejunal
mucosa by gluten compared with CS. Previou s
i nvestigators [12], especially Fry et al [39,40]
had emphasised that the majority of DH patients
have a virtually
normal villous
st r uct ure
bearing an increased population of EL.
It was instructive to apply image-analysi s
techniques
to the DH lesion in patients
before
gluten
restriction
in
order
to
compare
background mor phologic
changes
with
those
i nvolving the EL pool within surface (v illus)
and crypt epithelium (Fig . 9).
The data are
ranked according to VsE, thus demonstrating
the
progressive flattening of villous structure to a
degree identical
to that seen in untreated
CS
disease.
It is interesting
to note that crypt
hypertrophy appears early in the series
and is
present
in
some specimens whose surface
epithelial
volumes (VsEl had not fallen
below
the lower 95% confidence limits
for control
mucosae. This raises the intriguing
possibility
that crypt hypertrophy is not a compensatory
response to an exaggerated rate"of migration and
desquamation
of
surface
enterocytes
that
characterises
severe
villous
flattening,
but
rather
is due to
other mechanisms, as yet
unidentified.
Thus, the validity of the analogy
between enterocyte
loss
followed
by crypt
hypertrophy and excess erythrocyte
breakdown

Malabsorption Syndrome in GambianChildren
In a collaborative
study organised by the
Dunn Nutrition
Laboratory, Cambridge, UK, we
have been analyzing jejunal mucosae from young
children
from villages in the Fajara region of
Gambia.
These children
have a
severe
malabsorption
syndrome (not
apparently
due
either to dietary causes, giardiasis or an acute
infectious
enteritis)
in whom a pilot
study
revea led a jejunal lesion reminiscent of coeliac
disease:
they might therefore
provisionally
be
deemed to have a chronic 'tropical
sprue-like'
illness.
Our preliminary data are displayed
as for
DHpatients (Fig. 10} with vil lou s volumes (VsEl

1668

Imunopathology

vs,

t

4 .0

3.0

2.0
(x1cPpm3 )

3.0

-~~Mt
-~1 I

NV(SE)

[10910]
2 .0

t

I

Surface
Ep.Vol .
(VSE)

3.0

l

1.0

f"···

0

t

\ normal
crypts

1.0

(xl0

2.5

i~
v-v.

2
mal villi

2.0

1.5

6

1.0

) "11at"mucosai,
~m

3

)

0

+

2 .0

3 .0

rNV(SE)
[Log,o]

oo,

2.0
_
10

VCR

+

Cell-Mediated Responses
3

~A~
viii•

of Intestinal

NV(CRl

['0910]

Crypt
Ep.Vol.

-

l"

ormal crypts

1.0

(VcRl

3

2.0

t

(V\ ,----...
f.. ,.I
--+vl---..,..,\1'---"'-c•--------j

1.0

rNV(CR)
2.

[L09

10
)

1

Figure 9. Mucosae from 32 untreated DH patients
are arranged in decreasing order of surface
epithelial
volumes (V5 E), together with their
corresponding crypt epithelial
volumes (VCR), as
indicated
on LH axis (xl0 6 µm3 ). The three sets
of
horizontal
paired
l i nes
represent
95%
confidence 1 imits for lowest control VSE and
highest CS VsE, and uppermost crypt epithelial
volume (VsE) for control mucosae. RH axes are
logarithmic
scales for absolute populations
of
EL in surface
[Nv(SEJL and crypt [Nv(CR)]
epithelium.
Left hand villi that are within normal range
contain raised EL populations:
population
size
for surface epithelial
EL falls
as mucosae
flatten
(RH side).
In contrast,
crypt EL
abruptly rise
above upper
reference
range
(horizontal
single line)
in at least
seven
mucosae whose vil l ous volumes stil l lie within
the lower 95% confidence limit, but whose crypt
volumes exceed
normal control
values. As
VsE gradually
falls,
there
is
a slig ht
progressive increase in Nv(CR)-

Figure 10.
The format
of the diagram is
identical to Figure 9, but illustrates
data from
17 Gambian children with "tropical
sprue" type
malabsorpt i on. Several left hand villi
are of
normal volume, contain a high number of EL and
are associated with markedly hypertrophic
crypts
bearing their
own increased
population of
lymphocytes.
While crypt EL [Nv(cR)] remain
above upper reference range ( hori zonta l line),
note
that
surfac e epithelium
lymphocytes
[Nv(SE)] tend to drift downwards into control
range
(be l ow horizontal
line)
as mucosae
flatten. There is a striking re semblance between
these data and the immunopathological features
in untreated DHmucosae (Figure 9).

period over which it occurs, has never been
observed.
Note,
however,
that the reverse
proce ss during dietary
gluten exclusion,
is
surprisingly
long and require s 3-12 months on
average for complete resolution in children
[2],
and between 1-5 years in adult coeliac patients
[107].
One way of elucidating
this problem
directly is by gluten-challenge.

ranked from left to right:
note the surpris ing
simi larity
between both sets of data.
Notice
also the hypertrophy of the crypts in many
biopsies
in the absence of major reductions
in
VsE, and that they have high EL populations.
Likewise, villi
on left of diagram contain a
markedly
increased
population
of
small,
non-mitotic
lymphocytes while with more severe
lesions a fall in Nv(SE) occurs.
The similarity
in the drift of the mucosal
chanqes (from L to R in both conditions)
hints
at a common mode of progression,
and hence
pathogenesis.
However, the
difficulty
in
interpretation
is
that
each 'framework' is
static
and fails to answer the most important
question arising
from these data, i . e.,
in
becoming flat is it obligatory that the mucosa
passes through an identical series of changes in
each
patient.
There is currently no answer _to
this important question: the natural
in vivo
evolution
of a celiac flat mucosa, nor the time

The Inmunopathologic Effect of Gluten Challenge
Although much has been published on gluten
challenge [19],
all
studies when evaluated
together can be seen to lack uniformity of
approach, s ince much of the impetus has been
purely diagnostic, i . e ., to flatten
the mucosa
in order to prove gluten-sensitivity
.
In our laboratory it was thought desirable
to approach the problem in a more systematic
way, since it was argued that if the cel_iac
lesion is due to cell-mediated immune mechanisms
then a series of graded challenges (analogous to
performing a Mantoux test) might reveal detailed
information about
the
sequence
of changes
reflecting
the evolution
from normal villous
architecture
to that of avillous flattening.
We therefore
set out to chal lenge small
groups (~6) of well-treated CS patients
with a
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Figure 12. This diagram illustrates
sequent i al
immunopathologic changes
in small intestinal
mucosa in a gluten-sensitive
patient
challenged
orally with 6g Frazer fraction 3 (peptic-tryptic
digest) .
Format as described in Figure 9.
The
control
(pre-challenge)
biopsy (a) is normal .
At 12h and 36h post-challenge
(b,c) there is
already marked crypt hypertrophy exceeding upper
95% confidence limit for control crypt volumes
(VCR) while villi are still in control
range.
Nevertheless
both compartments are subject
to
major rises in EL content, but vihereas cr-ypt EL
population
[Nv(cR)] remains elevated, that in
villi
[Nv(SE)] falls as villi
approach 'flat'
range (d,e).
EL in specimen e revealed an
increa se in size and mitotic activity.

-20
0

--

3

72

~

Figure 11.
These are
group mean data for
treated
CS patients
challenged orally with
Frazer fraction
3 (peptic-tryptic
digest of
gliadin)
at doses of 100-1500mg per challenge .
There
is
a dose-dependent,
time-related
increment (shown on vertical
axis as net
percentage change over pre-challenge
control
values) in surface epithelial
lymphocytes .
The
lymphocytic
infiltrate
comprised
small,
non-mitotic
cells that had virtually
ceased by
36h post-challenge.
There was no response to
the control protein S-lactoglobulin
(horizontal
dotted line ).

At 12 and 36h pos t-challenge there i s no
statistical
change
in
villous
height (VsE
remains constant),
but there is a doubling of
crypt volumes (VcR) which persists
throughout
the challenge . At 60-84h, there is considerable
loss of villous height although true flattening
fails to occur . The events occurring within the
EL pool are striking.
At 12h the absolute
population of EL (Nv(SE)) in villous
epithelium
has almost doubled (note log scale) although the
lymphocytes are small and non-mitotic while at
later
times, they gradually fall in number in
parallel
with the progressive reduction in VsE·
In the crypts, EL rise throughout the challenge
and remain elevated at 84h. At 84h, their
size
has increased and the rate of mitosis has also
begun to accelerate.
In dynamic terms, we see for the first
time
the temporal evolution of events leading to
mucosal flattening
and which also precisely
recapitulate
the static
picture
suggested by
grouping mucosae as in DH (Fig. 9) and the
Gambian children with sprue-like
malabsorption
(Fig. 10). Although these challenge studies
are
continuing,
there is already strong evidence to
show that the
evolution
of a flat
mucosa
requires
progression
through
a series
of
specific
changes.
Most notable
is
the
observation
that crypt hypertrophy is an early
event, and not primarily a compensatory response
to villous flattening with its implied increased

peptic-tryptic
digest (PTO) of gliadin L58J and
to observe the effect s of each dose of PTO over
a 5d period, as described
in Methods . These
studies are still progressing.
In the smaller challenges
(Fig . 11), in
which oral doses of either 100, 500, 1000 or
1500mg of PTOwere employed, a dose-dependent,
time-related
accumulation of small, non-mitotic
lymphocytes into surface epithelium was observed
[58].
Despite the influx of EL, there was no
reduction
in VsE, rise in VcR, nor change in
total
length of basement membrane (per 104 µm2
muscularis mucosae) in any specimen analyzed.
It should also be noted that CS patients did not
react to S-LG, while control subjects showed no
response to
either
immunogen. The maximal
increment in EL was observed at 12h postchallenge, the effect having largely
disappeared
when the next
biopsy
was obtained at 36h
post-challenge .
With a 6gm PTOoral challenge,
a considerably more interesting
set
of data was
obtained,
as exemplified by one of the patients
in this group . The data are displayed as for DH
(Fig. 12), although the difference now is that
they represent
a sequential series
of mucosal
changes occurring with time in one individual.
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Figure 13. Initial biopsy (panel a) shows normal villi with considerable infiltration
of epithelium
by small, non-mitotic EL (panel b}. Second biopsy (panel c) reveals intermediate le sio n with "low"
villi.
Final biopsy (panel d} is characteristically
flat with epithelium containing both mitotic
(panel e, upper segment) and immunoblastoid (lower segment) EL. This sequence, somewhat simi la r to
those depicted in Figure 12, evolved over a period of ~4 years. Magnification bar s: a,c,d
l00µm:
b,e = l0µm.

observed in biopsies submitted to us for review
on another lady with long-standing malabsorption:
her
last
biopsy,
before
gluten
restriction,
was flat
and agai n
showed
characteristic
proliferative
activity of EL.
Both cases invite the suggestion that the
temporal evolution of the classic CS lesion may
involve an initial phase similar to (i) that
evoked by small-d ose gluten chal lenge s and (ii)
appearances noted
in
some first-degree
CS
relatives.

desquamation and loss of surface enterocytes.
Natural Evolution of the CS Lesion
The above studies stil l invite the criticism
that the dynamic spectrum of mucosal changes
brought about by graded challenges with gluten,
however interesting,
represents
an artificial
model of flattening . However, we have observed
certain patients in the University Department of
Medicine at Hope Hospital, in whom a s imilarly
evolving series of mucosal changes was observed
over several years. An example is shown (Fig.
13) of
mucosal biopsies
obtained
from a
60-yr-old
lady who presented us with a 20-yr
history of steatorrhea and nutritional
deficiencies, with an initial biop sy revealing normal
vi ll ous architecture
(s ubsequent review in our
laboratory
showed epithelium
full of small,
non-mitotic
(%MI
zero) lymphocytes (Figs.
13a,b}. No spec ific diagnosis had been made, but
gluten restriction
caused prompt improvement.
She relapsed six months later
and pancreatic
extracts were added. Two years later (Fig. 13c}
a further
biopsy showed 'ridged' villi
(%MI
0.03) and like the first, was thought to be
normal: an unrestricted diet was advised.
This
led to a rapid increase in diarrhea within six
months, and after another year she was referred
to our Unit, where a third biopsy (Figs . 13d,e )
now revealed complete flattening,
and large,
mitotic EL (%MI= 0.5). Nutritional
supplements,
anti-diarrhea l s and strict
gluten restriction
swiftly
brought
her
into
remission, with
improved well-being and subseque nt weight gain.
She remained well until lost to follow-up,
but
refused
additional
investigative
procedures
during that time.
The presumptive
diagnosis
was celiac
disease.
Nevertheless, her mucosal biopsies
(if
considered to
be representative)
showed a
hitherto
unrecorded
progression from villous
pattern with lymphoid infiltration
of epithelium
to a classic flat
lesion containing mitotic,
'immunoblastoid'
EL, evolving over a period of
3-4 years.
A similar mucosa l progression,
evolving more rapidly within two years, was

First-Degree Celiac Sprue Relatives
Several
extensive
family st udies have
revealed a prevalence rate of either
symptomatic
or asymptomatic ( 'latent')
celiac sprue with
classical
'flat'
biopsies
among
10-15%
first-degree
relatives [62,90,108, 30]. We have
recently completed a study of 52 fir st-degree CS
relatives
[80] in terms
of HLA st atus and
intestinal
morphology,
epithelial
lymphocyte
populations
and permeability
to 51 Cr-EDTA.
That an increase
in intestinal
permeability
predisposes
to CS disease was suggested by its
persistence
in several
people whose mucosal
biopsies were morphologically normal as a result
of many years of gluten restriction
[80,6].
Given the hereditary-genetic
background to CS
disease,
it was argued that first-degree
CS
relatives
might be expected to show defects in
permeability
if the
latter
is an important
risk-factor
in pathogenesis. Wewere careful
to
exclude from study all relatives who had al ready
been shown by jejunal biopsy to have a flat
biopsy, the
prevalence
rate
in our local
population
(15.5%) being
similar
to that
elsewhere in the UKand world.
None of the 52 relatives st udied had any
abnormality
in
villous
morphology,
and
permeability
was within
normal limit s (24h
excretion
of 51 cr < 3%). Unexpectedly, 38% of
these individual s revealed villous
epithelium
containing
an increased population of small,
non-mitotic
lymphocytes:
the numerical range
(413-1002) exceeded the 95% upper confidence
limit s for control biopsies, within which the EL
population s of the remaining CS relatives
fell
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b
Fi gure 14. I n a study of first -deg ree CS relatives,
some were found to have a normal vi llu s-be aring
mucosa (pane l c) in which epithe lium was heavily infiltrate d by small, non-mitotic lymphocytes (pa nel
d).

Mucosal appearance s i n the remainder were within normal limits
lOOµm: panels b,d = l Oµm.

(78- 395) (Fig. 14) .
The lymphoid infiltrate
did not appear
rel~ted to HLAstat us, s ince the frequency of
DR3
individual s in
the
normal 'group' of
relatives
was 50% thus providing an adequate
control for the seco nd group with in creased
numbers of vi ll ous EL. Furthermore,
it was
notable t~at two individuals i n the latter
group
were DR3 . Sin ce a l arge proportion ( 15.5%) of
CS re l ati ves wit h f l at mucosae were excluded
fro m this study, it is unclear whether the high
lymphocytic infi l trates could be a progressive
les i on, or at
l east
a "marker" i ndi cating
development of a flat lesion at some future
date.
Such a view is al so suggested by the
case-h i stories recorded in the previous section.
What is evident from this st udy i s that a
lymphocytic i nfil tra t e into villous
epithelium
does not necessar ily cause either
struct ural
abnormalitie s nor
alterations
in
mucosal
permeability. Other fa ctors may thus be required
for full disease expression: the natu re of such
factors i s at pre sent unknown.

(panel s a,b).

Bars: panels a,c

made for any tissue
component.
The three
stru ct ural components of
interest
are (i)
surface epithelial
volume ( VsE) (ii)
crypt
epithelial
volume (VCR) and (i ii) volume of
lamina propria (VL~ . Thus, irrespective
of the
degree of
abnormali ty
(z)
pre se nt in any
speci men, its component volumes are calculable,
valid and comparat ive, si nce they are always
related
to
the
same test
area (x,y) of
muscular i s mucosae (Fig . 1) . This diagram also
shows, despite the irregular
shape of those
components, that they may be simpl y displayed,
quantitatively,
as cubes of equivalent
vol ume.
A simi lar approach was used by Guix et al [43] .
The use of cubes provi des a convenient
model for evaluating ce ll type s within a given
str uctural component.
Component volume, V,
number of cells (N), and their resultant
dens ity
(D) per unit volume is give n by the relation D
N/V (Fig . 15) . This simple relationship
permi t s
constr ucti on of volu me-den sity curves [91] and
evaluation
of
the
effects
of varying one
component in re l ation to the other quantit ie s.
For example, it was shown [43,66 ] that the
(abso lute ) EL populat ion in untreated CS mucosa
lie s at the lower limit of normal. When EL are
'counted' by reference to epithelial
cell s [33],
a measure of density is obtained, which i s not
the same as absolute number, i.e., D F N. Wi th
our mathematical model, values of VsE and NsE
for a normal mucosa can be calculated:
if V is
then
progres s ively
reduced
to
values
commensurate with a flat mucosa while N is held
constant,
the effect of volume reductions
on D
can be examined (Fig . 16): thi s illustrates
how
density rapidly rises as the mucosa flattens
although the actual
s ize of the lymphocyte
population has
not
altered:
similar
events
clearly occur in celiac sprue.
In contrast,
crypt EL populations in CS are
increased presumably because crypt epithelium
does not exfo li at e. The decrease in surface EL

Extended Discussion
Morphometric Considerations
The result s i n all the se studies
derive
from a computerised
morphometric syst em of
analyzing inte stinal mucosa ,
in which x,y, z
coordinates
are
proje cted
into
the ti ss ue
sections.
The x,y coordinates define a constant
test area (10 4 µm2 ) that overlies the musculari s
mucosae, while the z scalar controls
structural
measurements in the vertical component of the
mucosa.
All data, obtained by drawing around
profiles
observed in the 2-dimensional plane of
the section,
are always related
to a known
length of
musculari s mucosa while repeated
measurements permit a statistical
reconstruction
of the origina l (3-dimensional)
structure.
A
relative
coefficient
of
variation
< 10%
indicates that sufficient measurements have been
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In addition to displaying mucosal
volumes 1n terms of equivalent
cube volumes
(Fig.
1),
this
model more
effectively
illustrates
the relationship between epithelial
volume (VE), the absolute number of contained
cells
(N) and their resultant
density D, in
terms of the relationship D = N;v.
Although CS epithelial
volume (V"E) is
decreased relative
to
control mucosae (V'E)
their populations
of
EL are approximately
equivalent
(N1 = N2 ) , such that the density of
CS cells
D2 exceed D1 , the density in control
mucosae: these concepts can be further
exploited
as demonstrated in Fig . 16.

Figure
16.
These graphs
i llustrate
the
important relationship between cell (EL) density
(expressed as
Nv,E on vertical
axis) and
epithelial
volume (VE) (shown on horizontal
axis) while N remains
constant.
As VE is
progressively reduced, the density of EL changes
little
through the range for control values (VE)
(open
box)
but
rises
acutely
and
disproportionately
when VE moves through the
range typical
of flat mucosae (shaded area).
This model emphasises the dangers inherent in
expressing cell population sizes in terms of
densities rather than absolute numbers.

populations
as flattening occurs is probably a
reflection
of the rapid desquamation of surface
epithelium which removes EL at a rate greater
than they can be replaced. This is, of course, a
speculative
deduction and no true data exist to
support or refute it.

upon which these
evident .

Type I and Type II Mucosa] Lesions in CS
It is
now evident that
two distinct
extremes of mucosal change exist . The type I
comprises normal villi
whose epithelium
is
filled
with
numerous,
small,
non-mitotic
lymphocytes.
This occurs in (i) many DH cases
(Fig. 9), in some 1° CS family relatives
(Fig.
14), and in
treated
CS patients
challenged
orally with FF3 in low dose (0.l-l.5g)
(Fig.
11). Conversely the type II lesion is seen in
untreated
CS, and a small proportion of DH
patients
who may have a severe lesion with, or
without, accompanying malabsorption (Fig. 9). In
Type II lesions, the mitotic activity
and mean
size of surface, and crypt, EL are
increased
(Fig. 17).
Some preli minary evidence is presented to
suggest that the evolution of a type II 'flat'
lesion requires
transition through an earlier
type I lesion
as
demonstrated (i) by our
sequential challenge data (Figs. 11,12) (ii)
in
some patients
spontaneously (Fig. 13) and as
hinted at (iii) by the graphica1 representation
of mucosae in DH (Fig. 9) or the malabsorption
syndr0me in Gambian children (Fig. 10). Clear ly,
although
many
details
require
further
documentation or substantiation,
the framework
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Mechanisms of Villous Flattening
Although we are still not in possession of
all
the
factors
that
result
in villous
flattening,
severa l important lead s have been
established.
Firstly, the T cell dependence of
villous
flattening
was demonstrated several
years
ago in
immunologically-driven
models
involving
worm
infestations
of
rats
(Nippostro ngylu s brasiliensis)
[34,35].
Further
s tudies
have elaborated
on these earlier
experiments,
involving
either
allograft
rejection
or graft-versus-host
reaction
(GVHR),
and have confirmed
the
effects
on mucosal
architecture
[60,61].
In these studies,
the
occurrence of
crypt
hypertrophy before any
villous
shortening
is apparent, was carefully
documented and emphasised as a major early event
in these reactions.
Allograft Rejection. Heterotopic grafts of
fetal
intestine
are
sterile
and la ck their
normal complement of lymphoid cel l s: thus while
the graft stroma
is
of donor origin,
the
lymphoid infiltrates
during
rejection
are
derived
from the
host
[32].
In
these
experiments the early onset of crypt hypertrophy
was initiated
by increases
in crypt cell
proliferation
from day 3
on~1ards.
A
statistically
significant reduction in vil lou s
height was generally only evident during the
second
week after
engraftment
[60,61].
Accompanyi ng the early crypt changes was an

M.N. Marsh
within 24h:
later
on,
some EL assume a
blast- li ke appearance and mitotic cells are also
present [86,87,32] . Again, these events recall
the type 1 CS lesion.
Other experiments have shown that enterocyte damage in
GVHR is
not
due to T
cell-mediated
cytotoxicity
[32,11,36].
During
GVHRthere is a boosting of NKcell activity
and
recruitment
of
such cells
into intestinal
tissues
f.88]: however depletion of NK cell
activity,
either
in host or donor, fails
to
prevent the anticipated immunopathologic effects
[116]. Thus it seems that the latter are due to
soluble mediators released by activated graft T
cells coming into
contact with host-derived
lymphocytes and macrophages [27,85]. The cells
initiating
the reaction are Lyt l+ (T helper)
cells
restricted
by I-A (MHC Class II) gene
products: these are DTHeffector T cells [89,44] .
IFN-y, a lymphokine secreted by activated
T
lymphocytes, is one agent known to stimulate
the
constitutive
expression
of
I-A (class
II)
antigen by crypt and surface epithelial
ce ll s
[4,16].
Thus I-A expression by enterocytes
is
probably a good 'immunohisto logic marker' of a
cell-mediated
(DTH) reaction
in intestinal
tissues
[101,102,104],
although the secondary
role of suc h expression by enterocytes (e. g., in
local antigen
pre sentat ion
[9,10])
is not
entirely
straightforward
and awaits further
detailed
clarification.
However, it seems
reasonable to conclude from observations
based
on GVHRmodels that class II antigen expression
neither
( i) implies nor (ii) inevitably
results
in, enterocyte damage.
Despite such a brief description
of an
extensive field of study, important lesson s to
be drawn are (i) that intestinal
damage i s a
dose-related
effect proportional to the degree
of disparity
at the MHClocus (ii)
that crypt
hypertrophy is an early feature of damage in
mild lesion s, in which normal-appearing villi
may be
infiltrated
by small, non-mito tic
lymphocytes (iii) that villous flattening
occurs
late and is T-cell dependent (iv) that t he
delayed appearance of blast-like,
mitotic EL is
delayed and (v)
that lesion development is
dependent on DTHeffector lymphocytes restricted
by MHCclass II antigens .

mitoses

0

TYPE

1'LESION

1 Asymptomatic
2 DH without

Relatives
Enteropathy

0

TYPE

2' LESION

1 Coeliac Malabsorption
2 DH with Enteropathy

3 Gluten Challenge

Figure 17.
Two distinctive
patterns
occur at
each end of
the gluten-induced
spectrum of
mucosal insults.
The Type 1 le sion, comprising normal villi
containing
a large population of non-mitotic,
small lymphocytes is seen in CS patients
after
small dose challenges; a large proportion of DH
patients;
and in some 1° CS relatives.
The
established
Type 2 'fl at' lesion,
comprising
large,
highly mitotic EL is seen in CS disease
and some DHpatients: the other feature of this
lesion is that while
the
size of the EL
population
in
crypt
epithelium
is markedly
increased,
that
in
surface epithelium lie s
within the control range: these differences
may
be due to
increa sed rates
of enterocyte
exfoliation from the surface epithelium only.

increase
in lamina propria lymphocytes, close ly
followed by an infiltrate
of lymphocytes into
surface epithelium [34]. These appearances are
identical to the type 1 CS lesion.
Allograft rejection represents a phenomenon
that is (i) thymus- dependent and (ii) in which
the extent of tissue damage is related
to the
degree of histocompatibility
differences
between
host and graft [110]. Analogically, it could be
stated that as the "challenge dose" increases,
progressively
more severe intestinal
damage is
produced.
Anti-graft
(cytotoxic)
antibody is
not involved [28 ] .
GVHR.Inte stina l damage is produced, along
with other tissue effects,
by injections
of
alloreactive
T lymphocytes and is conveniently
measured by the spleen index [106].
Avoiding
recognition
of donor lymphocytes as foreign by
the host-recipient
can be achieved with the use
of
neonatal
animals
( "immunodeficient"),
irradiated
hosts or semi-allogeneic
chimaeras
(F 1 hybrid host) [32].
Although in adults (CBA x BALB/c) the
effects on intestine are not marked, in neonatal
mice crypt hypertrophy and increased crypt cell
production (which correlate direct l y with spleen
index) occur without evident effect
on villus
size. However EL populations rise significantly

The I11111unopathologic
Spectrum of Cell-Mediated
Intestinal Damage
In the above summary, we can recognise t he
str uctural
features
already
recognised
in
var ious human enteropathies,
especially
CS and
dermatitis
herpetiformis . The parallelism
not
only
suggests
a common immunopathogenic
mechanism, but also that there are varied and
progressive
structural facets of cell-mediated
immunedamage to the small intestinal mucosa.
There are additional
features
common to
both, such as (i) the constitutive expression by
villous
and crypt enterocytes of MHC Class II
antigens,
(ii)
the
presence
of
expanded
populations of mast cells [78,109] and basoph1ls
[78]
within
the
lamina
propria,
(i i i)
alterations
in fluid
and ion transport
by
epithelium [14,15] and (iv) secondary changes in
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permeability
[8,6] that are probably due to the
generation of inflammation within the lamina
[7]. Another feature of altered
pathophysiology
involves changes in the activity of brush border
enzymes, such
as
disaccharidases,
but the
mechanisms governing these
changes are more
subtle than the
mere presence of immature
surface enterocytes resulting from an increased
rate of cell migration [32 ]. For example, it
has been shown that
varying rates of cell
migration
influence
the
enzyme maturation
profile
within
individual
enterocyte s [59].
This is clearly
a field ripe for further
explorations.
Parenthetically,
clinicians
might
also be wary of
jumping to the obvious
conclusion that gluten is directly
damaging to
surface enterocytes in CS : there is likely
to
be a less facile explanation for such events.
In considering
enterocyte
damage, it is
noteworthy that even in the most severe GVHR
reactions,
such damage i s
not
always
conspicuou s,
despite
(i)
the
presence of
increased numbers of EL and (ii) the boosting of
non-specific
T cell cytotoxicity
and NK cell
activity.
In this context, the fact that CS
crypts conta in a 5-6 fold increase in EL should
not be forgotten [19]. These EL are identical
to those in surfac e epithelium by a variety
of
criteria
[104,73,81]: yet if they are
cytotoxic
to surface enterocytes, it is strange that crypt
epithelium remains completely unscat hed, and i s
neither
inh ibited
in
it s vast hypertrophic
response nor ability to generate argentaffin,
goblet and Paneth
cells.
Furthermore, the
constitutive
expression of MHCClass II antigen
by crypt cells clearly does not le ad to their
'autoreactive'
destruction.
The ro le that changes in microvascular
perfusion of the mucosa may play in regulating
the functional
and structural
integrity
of
enterocytes
must also
be considered.
These
as pect s of pathophysiology have not been well
explored,
although
ultrastructural
le s ion s
documented within CS enterocytes
are highly
reminiscent
of
those
evoked by short -term
ischemia/anoxia in experimental animals [70,71].
CS occurs in genetically-predisposed
individuals (Al, 88, 0R3/7, DQw2)as a resu lt of wheat
ingestion.
Exte nsive
studies
of the target
tissue
of injury - the upper jejunal mucosa have provided
important
in sights
into the
immunopathology of the lesion . Analogous studies
of other
presumptive "immunological" enteropathies
such
as
tropical
sprue
[77,98],
giardia sis [1,119], and short-lived reactions
to
various food components (cow's milk protein,
soya, eggs and fish)
in young infants
have
revea l ed similar patterns of intestinal
injury
which,
in
part,
are
consistent
with
a
cell-mediated form of intestinal
injury [50].
It also appears that each of these conditions requires ·a specific
genetically-determined
host response to
the relevant environmental
immunogen, whether
that
be antigen(s)
of
microbial / parasitic
origin,
food-derived,
or
resulting
from discordances at the MHC class
I / II loci in allograft rejection or GVHR. The
role of genetic factors
in CS/DH has been
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ENVIRONMENTAL

IMMUNOGEN

(Food, microbial, parasitic, MHC)

Dose -----]~Other

I

environmental
factors

HOST RESPONSE

\

Normal response

Abnonn•i rnsponse

t

No tissue damage

~mage

Mild - Moderate~

t

Clinically
inapparent

Moderate - Severe

t

Malabsorption
syndrome

18 .
The degree of intestinal
damage
caused
by pre sumptive cell-mediated
immune
responses
to
a variety
of
unrelated
environmental stimu li is likely to be regulated
by host
responses .
Despite
these varied
stimuli,
the actual immunopathology observed in
affected mucosae is stereotyped and appears to
evolve through a series of recognisable
changes
and pattern s of injury.
Figure

reasonably well documented, but we also know
that giardiasis is dependent on genetic factors,
both in humans where HLA-812 may be relevant
[96], and in animals since BALB/c mice rapidly
clear the para s ite while C3H/He mice (like T
cell
deficient
animals)
have
defective
elimination
mechanism(s)
[114] .
Conversely,
there is no available
evidence for tropical
sprue, but since this condition does not affect
all
those
wholly
exposed to
the
same
environment, some restrictive
element must be
operative
and thus presumed to be host-derived
(Fig . 18).
The
various
immunopathologic studies
referred
to above have helped to bring such
apparently diverse conditions within a unitary
model of pathogenesis.
This framework seems now
to be well established and provides the data
required for recognizing either the "early" or
"late" phases of such reactions within human and
non-human intestinal
tissue.
For the future,
work concerned
with
the
elaboration
of
lymphokines, interferons
and leukotrienes,
as
well as other cell-derived
factors
from mast
cells,
basophils,
macrophages and lymphoid
cells,
and the
ro le
of the neuroendocrine
system, will need to be unravelled in order to
further
promote our
understanding of these
complicated tissue reactions.
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Figure 19.
Values of
VsE obtained for 14
untreated CS flat mucosae, and 15 untreated
flat
DH mucosae were individually scaled up to a mean
contro l value of 2.5 x 106 µm3 (horizontal
so li d
line) . The new proportional
val ues for EL
populations (Nv,sEl obtained by these procedures
lie above the upper 95% confid ence limit (dotted
line) for control mucosae. These derived dat a
are reminiscent of the Type 1 le sion.

Discussion with Reviewers

J.R. Poley : Does age have an influence on
particu l arly on mucosal
morphometric indices,
volumes
and
on
lymphocyte
compart ment
In
untreated
CS, and after
populations?
chal leng e?
Author:
In an extensive
study of various
control groups, whose ages range over five
decades of adult life, no effect
of age on
either mucosal compartment volumes, or on their
contained EL populations, has been apparent.
We
find that the same indice s in childrens'
mucosae
also are commensurate with those of adults.
J.R. Poley:
Was there adequate sampling of
biopsy speci mens to exclude the presence of
so-ca lled patchy le sio ns?
Author :
Patc hine ss of the mucosa l lesion only
occurs in
about
20% mucosae from either
untreated DH, or CS patients.
My opinion is
that far too much emphasis on mucosal patchiness
has been made than is warranted by the facts,
which have been consistent in three independent
published studies [123,128,129]:
it does not
appear to
have had much effect
on the
consistency of our results, as described above.
J.R. Poley :
What is
the
nature of the
l ymphocyte s - cytotoxic, NK, CD4or CD8 cells?
Author:
I assume that this query relates
both
toEL (i) normally pre sent within surface and
crypt epithelium and (ii) to those induced by
gluten chal leng e. In both circumstances
[te xt
refs.
29, 104] the majority of EL bear the CD8
antigen.
Whether more subt le changes in EL
populations occur after challenge has not been
investigated
in
depth.
Furthermore,
the
avai labil ity
of
newer sub-subset
markers
provides an opportunity
for further
deta iled
stu dy on this point.
A. Fergus on:
You have used your technique to
sca le up cry pt volumes fro m normal mucosae to
the level seen in CS and shown that the size of
the revised EL population sti ll falls
short of
th at in the untreated CS crypts, indicating
that
the marked increase of EL in the latter
is not
merely an effect of crypt hypertrophy.
In other
words there is an 'excess' of EL that is trul y
gluten-induced
[ text ref. 79]. I f you were to
sca le up the reduced surfa ce epithelial
volumes
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Fig ure 20.
For all 32 untreated DH patients,
the total
volume of epithelium (VEP x 106 µm3 )
obta ined by summating VsE + VcR per specimen,
has been plotted.
The majority fall within the
± 95% confidence limits ( horizontal paired soli d
line s) for 30 contro l mucosal specimens.
The
corresponding total EL populations
(Nv,EP ),
re presenting
the sum [Nv, sE + Nv CR ], lie
between
±95% confidence
limit s (horizontal
dotted line s) for the same contra l mucosae.
Although VEP i s fairly uniform throughout the
entire series, values for Nv,EP corresponding to
the right-hand 15 flat mucosae, are lower than
those
of
the
left-hand
specimens,
thus
suggesting a greater
loss
of EL from the
epithe li um when f l at.

of untreated CS mucosae to value s approximating
VsE for control mucosae, is the discrepancy in
the l ow values for surface EL obliter ated?
Author :
This is an inter esti ng point which our
model of quantitating mucosal biopsies permits.
This specific inter vention had not been carried
out, but the results sought by this question,
both for 14 untreated CS patients, and for the
15 DHpatients with f l at mucosae (Fig . 9), are
shown (Fig. 19). Each mucosa has been sca le d up
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to a value for VsE of 2.5 x 10 µm, which is the
mean for
30 controls
(10 young healthy
volunteers + 10 healthy
CS relatives
+ 10
disease-contro l
patients
without
mucosal
abnormality),
and the corresponding new values
for Nv,sE displayed on a logarithmic scale.
The
majority of values for Nv,sE lie above the 95%
upper
confidence
limit
for
control
EL
populations
in villous surface epithelium.
We
are back to the Type 1 lesion!
D. Moffitt : From Fig . 9, the impression is also
gained that there is no overall change in tota l
epithelia l volume (VsE + VcR = VEP) and that the
total EL population (Nv,SE + Nv,cR) may also not
vary. If so, this suggests that the conformation
of the mucosa (villous to avillous) and type of
EL present (small, non-mitotic,
to large and
mitotic)
are
the
basic
changes
present.
Furthermore,
high
EL mitotic activity
with
little
change in absolute count implies either
increased lo sses into the intestinal
lumen or
increased trafficking
back
into the lamina
propria.
Does this conf lict with the conclusion
that the density of EL increases with mucosal
flattening?
Author: By summating the values (VsE + VCR) and
~ + Nv,cR) , it can be seen (Fig.
20) that
total
epithelial
volume in the 32 untreated
DH
patient s (text Fig . 9) fall s within the upper
and lower 95% confidence limits for the 30
varied contro l mucosae referred to in the answer
to the preceding question.
Furthermore, the
total EL population tends to lie about the upper
95% confidence limits es tablishd
for the 30
control mucosae, although for the flat mucosae
(r ight-hand 15 values) Nv,EP drifts
downwards ,
again suggesting a net loss of EL in the most
seve rely damaged mucosae.
The fall
in the
absolute number of
EL (Nv, sE ) in sur face
epithelium is a real phenomenon and does not
conflict
with the fact that their density is
increased - it depends on what is being measured
and how those measurements are interpreted
(see
Fig. 16): my data suggest a considerable loss of
EL occasioned by the increased dynamic state of
epithelial
cell turnover when the mucosa is
flattened .
Note that although total epithelial
volume
is unchanged, the ratio of crypt to surface
epithelia l cells rises.
Since the functions of
these two population s of cells
are different,
the digestive-absorptive
capacity of a flattened
mucosa is considerably disturbed because of (i)
mucosal flattening
per se (ii)
damage to the
surface enterocytes and (iii) rapid migration of
cel l s, leading to (iv) a higher proportion of
'immature' cells
lining
the luminal surface.
Teleologically
it can be seen that in the
process of becoming flat we have an adaptive
respo nse that reduces antigenic
exposure and
uptake, as possibly limits the surface available
for colonization,
for
example, by worms or
parasites.
A. Ferguson: The proliferative
compartment in
CS mucosae is greatly expanded relative
to the
overa ll size of the
crypts.
Is there any
particular
pattern
in the distribution
of EL
between the
proliferative,
and maturational,
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compartments?
Author:
This distinction has not been formally
evaluated.
EL occur more in the upper one-half
of the crypts and therefore would extend right
across the maturational zone from the sur face
downwards and into the proliferative
zone.
I
think there is a closer relationship between the
presence of EL and the expression of MHC class
II antigen by crypt enterocytes - although which
comes first
and to what degree there is a
functional
connection [124], requires further
analysis.
A. Ferguson:
In untreated DHpatient s and in
the
first
degree
CS relatives
without
enteropathy,
have you considered whether these
represent
one end of a bimodal distribution
in
comparison with all others who form a continuum
from marginal
to
unequivocal
enteropathy
together
with
their
abnormalities
of
EL
populations?
Author: I doubt whether we are seeing a bimodal
population .
The DHcases you refer to (first
seven cases on left-hand side of text,
Fig. 9)
and the subgroup of first-degree
CS relatives,
have entirely normal morphology except for the
singu lar presence of an increased population of
small, non-mitotic
EL in surface (vi ll ous)
epithelium . Identical changes were induced with
oral challenge (O.l-l.5g
FF3) (Fig . 11) but
since a larger dose oral challenge evoked the
sequentia l appearances of type 1 and then type 2
lesions
during a 5-day period of observation
(Fig. 12), it seems evident that all three
distinct
pi ctures are successive phases in the
evolution of a flat mucosa. However, in our
challenge studies we were careful to use only
patients previously known to have a flat biopsy.
Whether those particular
DH patients
and CS
relatives
could be stimulated on challenge to
produce a more severe type of lesion is not
known. It i s conceivable that such individuals
are
genetically
restricted
from proceeding
further
along
the
evolutionary
pathway
described.
This i s an important point which
needs to be tested.
A. Ferguson: In the gluten-challenge series,
it
is presumed that the controls were inge s ting a
normal diet containing substantial
amounts of
gluten,
and that the treated
coeliac patients
were taking milk providing a substant ial amount
of B-lactoglobulin.
Although I do not think
this is likel y, presentation
of antigen not
encountered for many years and in the absence of
blocking antibody might theoretically
induce the
effects
observed.
Were level s of
local
secretory,
or syste mic, anti-gliadin
antibodies
by any chance measured in these patients
before
challenge?
J.R. Poley:
Were any of the CS patients
followed by serologic tests
(a nti-gl iadin and
anti-endomysial
antibodies)
to
parallel
morphologic findings?
Author:
Such antibody levels were not studied
before
challenge.
However, by challenging
controls
and CS patients
with gluten and
B-lactoglobulin
(on separate
occasions) and
showing that only
CS patients
responded to
gluten, it was felt that a specific,
immunologic
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response had been obtained.
In subsequent work,
we have tried to impose a milk-free
diet on
controls
before challenge, but they have not
been at all keen to
do that,
so that in
practise,
it is not easy to induce patients
to
confirm to what, admittedly, is a more ideal
experimental settin g for these challenges.
A. Ferguson:
Another
very
critical
point
concerns whether all the effects,
particularly
the later ones, can be attributed to the gluten
challenge
itself,
or
whether
an
initial
abnormality produced
by the immunopathologic
effect
of gluten leads to the evolution of a
range of secondary,
non-specific
immune and
other reactions
that extend, and amplify, the
effects of the gluten-targetted
immune response.
Although difficult
for the patient, it would be
interesting
to maintain
the
patient
on an
elemental diet
following
challenge for the
remainder of the study:
predict
that the
enteropathy would resolve rapidly within 24-48h.
Author:
We have not done this,
although the
point you raise is of considerable
theoretical
interest.
It might be possi ble to incorporate
this modification
into our chal lenge protocol
and compare results
with
our
'standard'
challenge at each dose level of gluten employed.
Incidentally,
it may not have been apparent,
but
all CS patient s remained 'gluten-free'
throughout
each series,
except for the single challe nge
dose of FF3.
A. Ferguson: The late appearance of lymphocytes
with mitoti c activity
in the infiltrates
in
various situations is fascinating.
Thi s could
be explained by different
stimuli
producing
mitosis
in the population of precursor
Els and
allowing enhanced migration /acc umulation of EL
within
the
epithelial
microenvi ronment,
irrespective
of mitotic activity.
If humans are
analogous to mice, one would expect a 2-3 day
delay between antigen
re-exposure
and the
appearance of ce ll s within the gut which had
·been stimulated within Peyer's patches migrating
via lymph and bloodstream.
Author:
It was previously shown [te xt ref. 66]
ttiatthe
ratio of EL traversing
the basement
membrane to
those
within epithelium
( "Flu x
Ratio")
was elevated,
suggesting
increased
lymphocytic trafficking
across
the basement
membrane in untreated CS mucosae, compared with
controls.
My own feeling i s that because of the
extremely
accelerated
loss
of
surface
enterocytes
from flat untreated CS mucosae, the
tempo of movement of lymphocytes into epithelium
is increased to "make good" their
continuing
loss into the lumen: hence also the raised flux
ratios.
In this regard, I believe that the
large EL that appear at this time are not
immunoblasts, but may be large immature cells
(i.e.
lymphoblasts)
reflecting
the
high
proliferative
rate of precursors
necessary to
maintain
the
size
of
the
EL population
(analogous to the presence of large nucleated
precursors
of erythroid and myeloid cell
lines
in haemolysis, or leucocytosis,
respectively).
The absence of activation markers [127] on these
large EL (i.e. Tac or transferrin)
also suggests
that they may not be immunoblasts. Furthermore,

if
they
did
reflect
gluten-triggering
of
gluten-sensitised
EL, then they should also be
see n in the earlier
'proliferative'
(Type 1)
lesion,
but here they are conspicuously
absent,
despite the fact that these infiltrate s are
gluten-dependent.
In this respect, it is correct
to suggest that these high infiltrate s may be
due to
antigen-induced
lymphocyte retention
within the epithelium.
It therefore
follows
that,
if the epithelium was not subject
to
destructive
influences
(Type 2 lesion),
the
established
flat
CS surface epithelium would
also contain an elevated EL population
(Fig.
19): the postulated high turnover of EL into
epithelium
in this situation might therefore
be
geared up to attempt this - although in reality
this aim is hardly achieved.
A. Ferguson:
I
completely
agree with the
concept that there
is
an early phase of
coeliac-like
enteropathy
in
which
EL
infiltration
and crypt
hyperplasia
are
predominant and that
vil lus
atrophy is a
distinct
and separate later phenomenon. It is
only in the villus atrophy phase that there i s
obvious enterocyte damage. I think I am right
in
the assumption that there are no features of EL
to differentiate
between these two states,
and
that you would agree that some factor other than
T cell mediated damage is likely
to be the
explanation
for
the
villus
enterocyte
abnormalities.
You published some years ago on
the sub-epithelia l fibroblast sheath,
and you
have made many observations on the connective
tissue
and vascular components of the lamina
propria,
in addition to the infiltrating
cells.
Have you any comments on abnormalities of these
structures,
or of the basement membrane, which
may be relevant to the enterocyte damage? Might
there be relative
ischaemia at villus
tips?
What about immunecomplexes?
Author:
The only differences in EL between the
proliferative
(Type 1) and destructive (Type 2)
lesion are the increased size of population
of
EL in the former, and the relative
increase
in
their diameters in the latter:
additional
TEM
studie5
would not
provide
differential
infor mati on. With regard to the mechanism of
enterocyte
damage, it is clear that EL do not
appear to be relevant
factors,
since they
evidently
cause no obvious damage to the mucosa
in the
Type 1 le sion.
Furthermore their
sustained
increase in the cry pts of Type 2
lesions without apparently affecting
the high
rate of crypt ce ll division; cry pt hypertrophy;
migratory capacity; ability to cytodifferentiate
into Paneth cells, argentaffin and goblet cells
and their
continued ability to synthesise
and
express MHC class II glycoproteins,
is al so
indicative
that EL are not agents of mucosal
destruction,
as
I
have consistently
argued
elsewhere [text ref. 73,79]. My own view is
that ischemia may be a very relevant factor
that
leads to impaired surface enterocyte
structure
and function.
Another
second factor
of
importance may be the release of connective
tissue
and basement membrane-degrading enzymes
from neutrophils and mast cells that constit ute
some of the major cell infiltrates
within lamina
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propria [text ref. 23,78]. The effect
of these
enzymes is probably to weaken the attachment of
surface enterocytes to the basement membrane and
thus impair their viability.
These points have
been explored,
together
with
the role of
antigen-a~tibody complexes, elsewhere [text ref.
70,71], but I have no firm data at this time.
A. Ferguson: Were there differences
in lamina
propria cell density when the coeliac relatives
with abnormalities of EL were compared with the
ot her s?
Author: Unfortunately this was not done.
Since
these
specimens
were
formalin-fixed/waxembedded, the chances
of doing good imageanalysis on such material, especially within the
lamina, would be very low.
A.
Ferguson:
In discussing
these coeliac
relatives
and also
the
DH patients,
the
important variable,
of dietary gluten intake,
has not been considered. There either may be a
variable tissue reaction, which is pathological,
to standard dietary gluten in about one third of
coelia c relati ves and the
majority of DH
patients;
or within a fairly uniform population
of gluten sensitive individuals, tissue changes
reflect
fairly
accurately
the dietary gluten
intake of the previous couple of weeks.
I may
say that we are in the process of analysing
jejunal
biopsy data from a large number of DH
patients
and have found not
only minor
abnormalities
of histology, particularly
of EL,
but also a very high proportion with abnormal
intestinal
permeability even when jejunal
biopsy
morphology is essentially
normal.
Author: This raises a very important point,
but
Tsan aspect of research in this field that is
rarely considered.
Nevertheless, it would be
very difficult
(a)
to
control and (b) to
determine the actual daily dietary
intake of
gluten per person.
Dose of gluten may be
important, as revealed for the first time in our
carefully-monitored,
sequential challenges with
FF3. Having said that, I am certain
that on
average, each person's daily intake of gluten is
fairly
constant and it may also be true for the
whole
population
that
person-to-person
variations
in daily gluten intake may not vary
to any great extent.
This has never been
investigated,
to my knowledge. Furthermore I
doubt, for example, whether the intake of gluten
varied much in the patient
(Fig. 13) whose
mucosa was observed to slowly flatten
over the
course of about 3 years.
This raises
another
new question as to what factor(s) controlled
the
slow evolution of her mucosa] lesion.
I think you are right about DH patients
all our DH patients
had increased mucosal
permeability
to
Cr-EDTA[text
ref. 8] even
after
they had been on a gluten-free diet for a
reasonable period
(in
some cases, several
years).
It is also
my impression that the
inflammatory
response
in DH mucosae
is
considerably
more vigorous than in CS patients,
even
though
their
degree
of
mucosal
architectural
distortion is considerably
less .
This also suggests a multiplicitiy
of operative
pathogenetic
mechanisms, ie,
a basic T-cell
mediated response that determines the degree of

mucosal architectural
disruption
(? determined
by host MHCclass II) upon which other secondary
inflammatory- or cytokine-driven
responses may
be enacted.
A. Ferguson:
It is conceivable that dietary
gluten induces a state of suppressed mucosal
immunity. Thus, if normal people (or people
incorrectly
diagno se d to have celiac disease)
were maintained on a gluten-free
diet for a
prolonged
period,
an altered
capacity to
subsequently respond to any antigen,
including
gluten, might be observed.
Author : We have not challenged any person
falling
i nto
the
category
suggested.
The
proposal,
however, is intere sting in terms of
orally-induced
tolerance
and the influence of
prolonged
dietary
antigenic
restriction
on
mechanisms of local immunesuppression.
J.R. Poley: Not mentioned are possibilitie s of
lectin-mediated
damage of small bowel mucosa,
which has been postulated by several groups as an
important pathogenic mechanism, and this reviewer
believes that such hypothesis should be included
in the di scussion.
Author:
I
note
your
use of
the word
'postulated'!
The theory that gluten might act
as a "lectin" (in other words, attach itself
to
some kind of cell receptor) was proposed over
ten years ago [130]. It was supported by the
i solation of a glycopeptide shown to damage CS
mucosa [125], that damage being caused by gluten
attachment to an abnormal receptor expressed by
surface enterocytes in such patients.
Another
group implied that crypt enterocytes
(admittedly
from rats - if thTsTs at all relevant)
bind
gluten via oligomannosyl residues [126]. It is
my guess that we all suspect there are receptors
on cells
that bind gluten, although I am not
clear as to why such receptors
have to be
aberrant.
But if this is so, why glorify
that
principle
into a new theory of pathogenesis?
Surely we just have to get on and determine the
character istic s of the relevant
receptor.
Nor
does it follow that attachment of gluten to the
membrane s hould necessarily cause that cel l to
be ki lled, which is a corollary of the proposal.
Finally,
these notions have to be squared with
all the immunopathologic features
of gluten
sensitivity
described in this paper . The latter
fit
more easily
into
the
scheme of a
cell-mediated
immune response rather than to
some unproven ideas
about an abnormal cell
receptor.
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